| Kevin Yi, MD | |
|
31675 Pacific Hwy S, Federal Way, WA 98003-5407 | |
| (253) 215-1093 | |
| (253) 215-1094 |
| Full Name | Kevin Yi |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 31675 Pacific Hwy S, Federal Way, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124558465 | NPI | - | NPPES |
| 2191625 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A158654 (California) | Secondary |
| 207Q00000X | Family Medicine | MD61176284 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highline Medical Center | Burien, WA | Hospital |
| St Joseph Medical Center | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Franciscan Medical Group | 0547173866 | 1115 |
News Archive
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
A two- or three-drug combination is more effective at reducing intrapartum HIV acquisition than zidovudine monotherapy in babies who are at high risk for transmission, a study in The New England Journal of Medicine shows.
BioSante Pharmaceuticals, Inc. today announced that results of an evaluation of its 2A/Furin technology by Novartis Pharma AG in its industrial antibody CHO expression system were published in the Journal of Applied Microbiology & Biotechnology. The results demonstrate that the 2A/Furin technology was integrated successfully into a plasmid-based, industrial-scale, CHO antibody cell line development process, with minimal optimization required.
CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, announced that the Centers for Medicare and Medicaid Services ("CMS") has established a national rate in The Medicare Program Final Rule for the technical component of mobile cardiovascular telemetry (CPT Code 93229).
With findings highlighted on a recent cover of Developmental Cell , researchers at Weill Cornell Medical College in New York City have shed important new light on key trafficking mechanisms within epithelial cells. Epithelial cells line the outside of nearly all organs.
› Verified 3 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
A two- or three-drug combination is more effective at reducing intrapartum HIV acquisition than zidovudine monotherapy in babies who are at high risk for transmission, a study in The New England Journal of Medicine shows.
BioSante Pharmaceuticals, Inc. today announced that results of an evaluation of its 2A/Furin technology by Novartis Pharma AG in its industrial antibody CHO expression system were published in the Journal of Applied Microbiology & Biotechnology. The results demonstrate that the 2A/Furin technology was integrated successfully into a plasmid-based, industrial-scale, CHO antibody cell line development process, with minimal optimization required.
CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, announced that the Centers for Medicare and Medicaid Services ("CMS") has established a national rate in The Medicare Program Final Rule for the technical component of mobile cardiovascular telemetry (CPT Code 93229).
With findings highlighted on a recent cover of Developmental Cell , researchers at Weill Cornell Medical College in New York City have shed important new light on key trafficking mechanisms within epithelial cells. Epithelial cells line the outside of nearly all organs.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Yi, MD 31675 Pacific Hwy S, Federal Way, WA 98003-5407 Ph: (253) 215-1093 | Kevin Yi, MD 31675 Pacific Hwy S, Federal Way, WA 98003-5407 Ph: (253) 215-1093 |
News Archive
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
A two- or three-drug combination is more effective at reducing intrapartum HIV acquisition than zidovudine monotherapy in babies who are at high risk for transmission, a study in The New England Journal of Medicine shows.
BioSante Pharmaceuticals, Inc. today announced that results of an evaluation of its 2A/Furin technology by Novartis Pharma AG in its industrial antibody CHO expression system were published in the Journal of Applied Microbiology & Biotechnology. The results demonstrate that the 2A/Furin technology was integrated successfully into a plasmid-based, industrial-scale, CHO antibody cell line development process, with minimal optimization required.
CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, announced that the Centers for Medicare and Medicaid Services ("CMS") has established a national rate in The Medicare Program Final Rule for the technical component of mobile cardiovascular telemetry (CPT Code 93229).
With findings highlighted on a recent cover of Developmental Cell , researchers at Weill Cornell Medical College in New York City have shed important new light on key trafficking mechanisms within epithelial cells. Epithelial cells line the outside of nearly all organs.
› Verified 3 days ago
Dr. Allen Charles Alleman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 34616 11th Pl S, Ste #4, Federal Way, WA 98003 Phone: 253-927-9460 Fax: 253-927-2168 | |
Charanjit Virk, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 31675 Pacific Hwy S, Federal Way, WA 98003 Phone: 253-215-1093 Fax: 253-215-1094 | |
Dr. Christine Li-huan Tam, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 S 320th St, Federal Way, WA 98003 Phone: 253-874-7958 | |
Peter Littlewood, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 33431 13th Pl S, Federal Way, WA 98003 Phone: 253-874-7634 Fax: 253-874-7635 | |
Dr. Carla Podgurecki, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 34616 11th Pl S, Ste 4, Federal Way, WA 98003 Phone: 253-927-2150 Fax: 253-927-2851 | |
Dr. Arthur T. Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 34515 9th Ave S, Federal Way, WA 98003 Phone: 253-835-8100 | |
Robert Michael Dini, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 32018 23rd Ave S, Federal Way, WA 98003 Phone: 253-839-3030 |